Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from ADMA Biologics ( (ADMA) ).
ADMA Biologics, Inc. has reassured analysts that the recent change in auditors, detailed in their latest report, will not affect the financial projections for the years 2024-2025. The company’s management confirmed that the transition of auditors is expected to proceed without impacting their previously stated financial guidance.
See more data about ADMA stock on TipRanks’ Stock Analysis page.